Suren Dutia

Mr. Suren G.
Dutia is an Independent Director at Citius Oncology, Inc. and an Independent Director at Citius Pharmaceuticals, Inc. He is on the Board of Directors at Citius Oncology, Inc., Flint Rehabilitation Devices LLC, Vahan Technologies India Pvt Ltd. and Citius Pharmaceuticals, Inc. Mr. Dutia was previously employed as an Independent Director by AccelPath, Inc., an Independent Director by Technest Holdings, Inc., a Chairman by AccelPath LLC, a Chief Executive Officer by The Indus Entrepreneurs, a President & Chief Executive Officer by Photomatrix Corp., a Chairman, President & Chief Executive Officer by Xscribe Corp, and a President by Acterna Corp.
He also served on the board at Otter Products LLC, TreeFrog Developments, Inc., Anvita, Inc. and Nanopore Diagnostics LLC.
He received his undergraduate degree from Washington University in St. Louis, a graduate degree from Washington University in St. Louis and an MBA from the University of Dallas.